Seguir
Elise Koch
Elise Koch
Dirección de correo verificada de medisin.uio.no
Título
Citado por
Citado por
Año
The relationship between cannabis use, schizophrenia, and bipolar disorder: a genetically informed study
W Cheng, N Parker, N Karadag, E Koch, G Hindley, R Icick, A Shadrin, ...
The Lancet Psychiatry 10 (6), 441-451, 2023
212023
Sex-specific effects of polygenic risk for schizophrenia on lifespan cognitive functioning in healthy individuals
E Koch, L Nyberg, A Lundquist, S Pudas, R Adolfsson, K Kauppi
Translational Psychiatry 11 (1), 520, 2021
202021
Interactome overlap between schizophrenia and cognition
E Koch, B Rosenthal, A Lundquist, CH Chen, K Kauppi
Schizophrenia research 222, 167-174, 2020
182020
How real-world data can facilitate the development of precision medicine treatment in psychiatry
E Koch, AF Pardiñas, KS O’Connell, P Selvaggi, JC Collados, A Babic, ...
Biological Psychiatry, 2024
142024
Candidates for drug repurposing to address the cognitive symptoms in schizophrenia
E Koch, K Kauppi, CH Chen
Progress in Neuro-Psychopharmacology and Biological Psychiatry 120, 110637, 2023
102023
Drug repurposing candidates to treat core symptoms in autism spectrum disorder
E Koch, D Demontis
Frontiers in Pharmacology 13, 995439, 2022
102022
Polygenic overlap with body-mass index improves prediction of treatment-resistant schizophrenia
KS O'Connell, E Koch, HÇ Lenk, IA Akkouh, G Hindley, P Jaholkowski, ...
Psychiatry research 325, 115217, 2023
92023
Genomics yields biological and phenotypic insights into bipolar disorder
KS O’Connell, M Koromina, T van der Veen, T Boltz, FS David, JMK Yang, ...
Nature, 1-12, 2025
52025
Polygenic liability for antipsychotic dosage and polypharmacy-a real-world registry and biobank study
E Koch, A Kämpe, M Alver, S Sigurðarson, G Einarsson, J Partanen, ...
Neuropsychopharmacology 49 (7), 1113-1119, 2024
52024
APOE ɛ4, but not polygenic Alzheimer’s disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individuals
S Håglin, E Koch, F Schäfer Hackenhaar, L Nyberg, K Kauppi
Scientific Reports 13 (1), 8433, 2023
52023
Polygenic risk for schizophrenia has sex-specific effects on brain activity during memory processing in healthy individuals
E Koch, L Nyberg, A Lundquist, K Kauppi
Genes 13 (3), 412, 2022
42022
Longitudinal effects of using and discontinuing central nervous system medications on cognitive functioning
E Koch, K Johnell, K Kauppi
Pharmacoepidemiology and Drug Safety 32 (4), 446-454, 2023
32023
Pleiotropic and sex-specific genetic architecture of circulating metabolic markers
D van der Meer, Z Rahman, A Ottas, P Parekh, G Kutrolli, S Stinson, ...
medRxiv, 2024.07. 30.24311254, 2024
22024
Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in aging
A Supiyev, R Karlsson, Y Wang, E Koch, S Hägg, K Kauppi
Neurobiology of Aging 126, 103-112, 2023
22023
Genome-wide meta-analyses of non-response to antidepressants identify novel loci and potential drugs
E Koch, T Jurgenson, G Einarsson, B Mitchell, A Harder, LM García-Marín, ...
medRxiv, 2024.07. 13.24310361, 2024
12024
Polygenic overlap with granulocyte counts identifies novel loci for clozapine metabolism and clozapine-induced agranulocytosis
E Koch, AA Shadrin, N Parker, SK Lock, RL Smith, O Frei, AM Dale, ...
Neuropsychopharmacology, 1-9, 2025
2025
Charting the shared genetic architecture of Alzheimer's disease, cognition, and educational attainment, and associations with brain development
P Jaholkowski, S Bahrami, V Fominykh, GFL Hindley, M Tesfaye, ...
Neurobiology of Disease 203, 106750, 2024
2024
F75. PREDICTION OF TREATMENT-RESISTANT SCHIZOPHRENIA USING REAL-WORLD DATA AND MULTIMODAL ANALYTICAL TOOLS
E Koch, P Parekh, HÇ Lenk, A Shadrin, N Parker, S Stinson, K O'Connell, ...
European Neuropsychopharmacology 87, 246, 2024
2024
W16. LEVERAGING THE GENETICS OF MAJOR PSYCHIATRIC DISORDERS TO PRIORITIZE POTENTIAL DRUG THERAPIES AND TARGETS
N Parker, E Koch, A Shadrin, J Fuhrer, G Hindley, S Stinson, O Frei, ...
European Neuropsychopharmacology 87, 108-109, 2024
2024
Genome-wide association analysis of treatment resistant schizophrenia for variant discovery and polygenic assessment
HÇ Lenk, E Koch, KS O’Connell, RL Smith, IA Akkouh, S Djurovic, ...
Human Genomics 18 (1), 108, 2024
2024
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20